New England Compounding Center

How the NECC Case Changed Compounding PharmacyBecause of the NECC Case, the nation has a much more consistent approach toward regulating and overseeing compounding pharmacies.
Trial of NECC pharmacist underwayBarry J. Cadden is charged with second-degree murder under the RICO Act.
Feds seize $18 million from NECC ownersProsecutors seized $18 million from accounts linked to the owners of the defunct New England Compounding Center, whose tainted products led to the 2012 meningitis outbreak that killed at least 64 people and sickened about 750.
NECC pharmacist owner charged with second-degree murderThe owner and head pharmacist of the now-defunct New England Compounding Center (NECC), based in Framingham, Mass., and the supervisory pharmacist were charged with 25 counts of second-degree murder in seven states, more than two years following a nationwide fungal meningitis outbreak, according to December 17 statement by the U.S. Justice Department.
Crackdown on drug compounders spurring more recallsFollowing the 2012 fungal meningitis outbreak that killed 64 people and sickened hundreds, FDA tightened regulations on compounders like the New England Compounding Center in Massachusetts to which the tainted drugs were linked.
Pharmacist connected to 2012 meningitis deaths arrestedFederal agents Thursday arrested the former supervising pharmacist of New England Compounding Center in Massachusetts, which in 2012 provided tainted drugs that led to a fungal meningitis outbreak that killed 64 people and sickened more than 700.
New compounding regulations will greatly enhance safety: FDAFDA thinks it got some, if not all, of what it needed to help it regulate compounding pharmacies.
Senate passes stricter compounding rulesThe U.S. Senate has voted overwhelmingly to adopt tighter regulations for compounding pharmacies and to create a national system that tracks prescription drugs from manufacturers to pharmacies.
NCPA CEO testifies before congressional committeeB. Douglas Hoey, CEO of the National Community Pharmacists Association, this week testified before a congressional committee considering tightening FDA oversight of compounding pharmacies following last year’s New England Compounding Center’s fungal meningitis tragedy.